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ABSTRACT  The small protein modifier, ubiquitin, can be covalently attached to proteins in the 
process of ubiquitylation, resulting in a variety of functional outcomes. In particular, the most 
commonly-associated and well-studied fate for proteins modified with ubiquitin is their ultimate 
destruction: degradation by the 26S proteasome via the ubiquitin-proteasome system, or diges-
tion in lysosomes by proteolytic enzymes. From the earliest days of ubiquitylation research, a 
reliable and versatile “cell-in-a-test-tube” system has been employed in the form of cytoplasmic 
extracts from the eggs and embryos of the frog Xenopus laevis. Biochemical studies of ubiquitin 
and protein degradation using this system have led to significant advances particularly in the study 
of ubiquitin-mediated proteolysis, while the versatility of Xenopus as a developmental model has 
allowed investigation of the in vivo consequences of ubiquitylation. Here we describe the use and 
history of Xenopus extract in the study of ubiquitin-mediated protein degradation, and highlight 
the versatility of this system that has been exploited to uncover mechanisms and consequences 
of ubiquitylation and proteolysis. 
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Introduction
Proteins are created through transcription and translation from 
DNA to RNA, and then finally synthesized at the ribosome (Crick, 
1970). In addition to their production, proteins are also destroyed 
to regulate their levels, terminate their function and recycle their 
constituent amino acids for future protein syntheses. The study 
of protein catabolism is a relatively recent area of research. De-
spite early observations that proteins were broken down and their 
components reused (Schoenheimer et al., 1939; Schoenheimer, 
1942), there was significant resistance to the concept that proteins 
were not persistent, and degraded intracellularly (Hogness et al., 
1955). It was only after extensive investigation (Hershko et al., 
1980; Schimke and Doyle, 1970; Simpson, 1953) that protein 
degradation came to be accepted, and the ubiquitin (Ub) protein 
was identified as a mediator of ATP-dependent protein degrada-
tion (Ciehanover et al., 1978; Wilkinson et al., 1980).
Ub can be covalently attached to other proteins in the post-
translational modification known as ubiquitylation. Ubiquitylation 
of proteins can result in a variety of signaling roles (Kerscher et 
al., 2006), but the best studied outcome of ubiquitylation is protein 
degradation. Ub-mediated proteolysis can be achieved through 
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degradation by the 26S proteasome through the Ub-Proteasome 
System (UPS) (Glickman and Ciechanover, 2002), or by diges-
tion in organelles called lysosomes using proteolytic enzymes 
(Schnell and Hicke, 2003). 
The study of protein degradation and ubiquitylation continues 
to be a highly active and continuously-evolving field (as reviewed 
in (McDowell and Philpott, 2016)), one which has taken advan-
tage of a number of model systems, and for biochemical studies, 
the frog Xenopus has played an important role. In particular, 
Xenopus offers the unique advantage of the ability to generate 
cell-free cytoplasmic extracts, which contain soluble proteins 
capable of carrying out the biochemical modifications required for 
protein ubiquitylation and destruction, facilitating many important 
advances in this field. Here, we describe the Xenopus cell-free 
cytosolic extract system and illustrate its utility in the study of 
protein ubiquitylation and degradation.
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Xenopus extract systems
Xenopus is an ideal model organism for biochemical studies due 
to its unique tractable extract system; milliliter volumes of cytosol 
readily generated from the thousands of eggs a single female frog 
can lay in one day can be used to study ubiquitylation and protein 
destruction events in vitro. Cytosolic extracts were first generated 
using unfertilized eggs from Xenopus laevis to demonstrate the 
assembly of chromatin from DNA (Laskey et al., 1977), but have 
been readily adapted for study of a variety of biochemical and 
cell biological regulatory mechanisms. The extracts that are used 
most commonly to investigate mechanisms of ubiquitylation are 
“cell cycle” extracts. These have been further modified over time 
to suit the requirements of the researcher, and often developed 
from the protocols laid down by Andrew Murray (Murray, 1991). 
Activated interphase cell cycle extracts, made using the general 
protocol illustrated in Fig. 1, were first developed by Manfred Lohka 
in the lab of Yoshio Masui using Rana pipiens cytosol to study 
pronuclear formation with Xenopus laevis sperm nuclei (Lohka 
and Masui, 1983; Powell, 2005). Modified versions, which still 
retained activity after extract was frozen and thawed, were used 
to study DNA replication (Blow and Laskey, 1986) and, as we will 
discuss later, to study cyclin degradation. These studies involved 
both “low-speed” extracts (generated after low speed centrifugation 
that include light membranes, ribosomes and nuclear envelope 
(Felix et al., 1989b)) and “high-speed” extracts (generated after 
an additional second, faster centrifugation to remove membranes 
and ribosomes (Felix et al., 1989a)). Extracts that could go through 
multiple cell cycles were also developed (Hutchison et al., 1987; 
Murray and Kirschner, 1989). In addition, non-activated or cyto-
static factor (CSF)-arrested meiotic metaphase extracts have been 
generated, replicating the environment of the unfertilized egg and 
these could later be activated with the addition of calcium ((Lohka 
and Maller, 1985) and refined (Murray et al., 1989)). Protocols for 
both activated interphase and CSF-arrested mitotic extracts were 
described in detail by Murray (Murray, 1991). In addition to egg-
based extracts, we have also used embryonic extracts, generated 
by centrifugation of embryos at particular stages of development, 
to mimic developmental stages such as neurogenesis (McDowell 
et al., 2010). Protocols for the preparation of a variety of cytosolic 
extracts to answer many experimental questions can be found at 
the community portal for the Xenopus community, Xenbase (www.
xenbase.org/, (James-Zorn et al., 2015; Karpinka et al., 2015)).
The utility of the Xenopus extract system to study a variety 
of biological problems is clear (e.g., (Murray, 1991; Nikos, 2012; 
Zyłkiewicz and Stukenberg, 2014) and many others). Here we are 
focusing on its use in the study of proteolysis, where the simplic-
ity of the ubiquitylation and degradation assays that the extract 
system allows has been key to the significant advances that have 
resulted (see (Klotzbucher et al., 2002; Salic et al., 2000; Vosper 
et al., 2009) for examples of Ub protocols). In addition, it has been 
straightforward to determine how biochemical mechanisms relate to 
the situation in vivo by using the developmentally tractable Xenopus 
embryo system. Importantly, mechanisms identified in frog have 
been widely shown to be conserved in mammalian systems, dem-
onstrating the utility of this “cell-in-a-test-tube” analytical approach.
The machinery of ubiquitylation
The pathway leading to UPS-mediated protein degradation is 
now well characterized and is discussed in more detail elsewhere 
((Hershko and Ciechanover, 1998; McDowell and Philpott, 2013; 
McDowell and Philpott, 2016; Varshavsky, 1997). In brief, Ub is 
activated by an E1 enzyme (Hershko et al., 1981), passed to an 
Ub-conjugating (E2) enzyme (Hershko et al., 1983) and from 
there to a substrate protein, specified by the particular E3 ligase 
that binds both the substrate and the E2 (Hershko et al., 1986). 
Multiple rounds of ubiquitylation on Ub itself can then follow to 
Fig. 1. Xenopus laevis egg extract systems in ubiquitylation studies. 
(A) Xenopus laevis are induced with hormone to lay eggs; (B) eggs are 
collected and their jelly coats removed; (C) eggs are activated using calcium 
ionophore to mimic fertilization and direct entry into interphase. Activated 
eggs are then spun at high speeds in a centrifuge to separate into (D) (i) 
lipid, (ii) cytoplasmic, and (iii) pigment granule and yolk platelet layers. (E) 
The cytoplasmic layer is taken and used for in vitro studies: for example, 
(F) in vitro translated radiolabelled protein is added to extract supplemented 
with Ub and ATP, and aliquots removed at various time points to assay 
degradation of protein over time; and (G) in vitro translated radiolabelled 
protein is added to extract supplemented with tagged Ub and the protea-
some inhibitor MG132, and after an incubation period antibody-coated 
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create chains of polyUb. The polyUb modification most commonly 
understood to target proteins for UPS-mediated degradation is a 
tetramer of K48-linked Ub moieties (Thrower et al., 2000). However 
many novel chains, of homotypic, heterotypic, and even branched 
topologies are contributing to the study of “atypical” chain ubiqui-
tylation (Komander, 2009). It was observed that purification of the 
Anaphase-Promoting Complex/Cyclosome (APC/C), a cell-cycle 
dependent component of the ubiquitylation machinery, from Xeno-
pus extract at different salt conditions led to the formation of Ub 
chains of differing lengths and in particular showed the capacity, 
at least in vitro, for the APC/C to form K11-, K48- and K63-linked 
polyUb chains targeting protein substrates for degradation (Kirk-
patrick et al., 2006). Upon further refinement, this led to work on 
the precise mechanism for the formation of K11-linked chains by 
the APC/C using the specificity conferred by the E2, UBE2S (Wu 
et al., 2010). The Xenopus system has played a central role in 
identifying which proteins are targeted for degradation and when.
Discoveries of Degrons and cell cycle regulated 
proteolysis
The use of Xenopus extracts has been central to our understand-
ing of mechanisms that regulate the destruction of proteins to bring 
about cell cycle transitions, as they can readily be manipulated 
to mimic the cellular conditions of interphase and mitosis and it 
has been known for a long time that cell cycle progression is ac-
companied by the cyclical synthesis and destruction of a number 
of proteins (Koepp, 2014). 
Global Ub metabolism is not obviously regulated by the cell 
cycle; using cycling Xenopus egg extract, it was possible to show 
that the levels of Ub did not change with the cell cycle phase; the 
rates of conjugation, protein degradation, and isopeptidase activity 
all remained constant throughout the course of the cycling extract 
experiments (Mahaffey et al., 1993). However, some proteins such 
as cyclins are destroyed at specific points in the cell cycle (Glotzer 
et al., 1991). The authors concluded that, therefore, cell cycle dif-
ferences in cyclin degradation could not be accounted for by any 
obvious global differential Ub kinetics in different phases of the cell 
cycle, but instead must result from individual regulation of specific 
proteins. In fact, the experiments by Glotzer et al., suggested that 
the recognition of cyclin B by the ubiquitylation machinery itself 
promotes the entry of the cell cycle into anaphase ((Glotzer et al., 
1991); prior to this work, only one other case of physiological regu-
lation through Ub-mediated degradation had been identified, the 
plant protein phytochrome (Jabben et al., 1989)). In this landmark 
study, Glotzer and colleagues found that the N-terminal region of 
cyclin B was required for its degradation in a mitotic extract system 
and that cyclin B was itself ubiquitylated (Glotzer et al., 1991). In 
the absence of inhibitors of ubiquitylation or proteasomal inhibi-
tors that had yet been described, the authors instead were able 
to demonstrate the link between ubiquitylation and degradation of 
cyclin B by calculating the kinetics of protein degradation compared 
with the flow of cyclin B through ubiquitylated intermediates (Glotzer 
et al., 1991). 
As well as demonstrating the role of cyclin B destruction in the 
cell cycle, these and further Xenopus extract experiments have 
shown us that cell cycle regulated destruction of proteins such as 
cyclins relies on timed degradation orchestrated by sequences 
known as degrons (Glotzer et al., 1991; King et al., 1996; Pfleger 
and Kirschner, 2000; Reed, 2003; van der Velden and Lohka, 
1993). Degrons are the minimal signals within proteins that result 
in their targeting for degradation by proteolytic machinery (Ravid 
and Hochstrasser, 2008). Here we will discuss two well-known 
degrons identified using Xenopus extract systems that are tar-
geted by the E3 ubiquitin ligase Anaphase Promoting Complex/
Cyclosome (APC/C see below): the KEN (Lys-Glu-Asn) box and 
Destruction (D-box, Arg-X-X-Leu).
The D-box was first identified during the early investigations of 
the degradation of the cell cycle regulator cyclin B, showing that 
a particular region of the N-terminus of the cyclin was necessary 
and sufficient to target for degradation in Xenopus mitotic extract; 
stable entry of extract into mitosis could be brought about by ad-
dition of a form of cyclin B with the first 90 amino acid residues 
deleted (a technique still used to generate mitotic egg extract), 
while adding this N-terminal portion of cyclin to other proteins 
was enough to trigger their proteolytic degradation (Glotzer et 
al., 1991). The characterization of the precise degron, the D box, 
within the Cyclin B N-terminal region was further refined using a 
mutagenesis approach, followed by investigation of the kinetics of 
protein degradation in Xenopus extract systems (King et al., 1996). 
Furthermore, important differences between control of cyclins A and 
B destruction were also identified, resulting from differing residues 
within their respective degrons (King et al., 1996).
The discovery of the KEN box, a distinct degron targeting pro-
teins for cell cycle regulated destruction, using Xenopus extract 
highlighted an important mechanism for cell-cycle regulation of 
protein degradation by the APC/C multi-component E3 ligase (see 
below). The association of Cdc20 with core components results in 
the mitotically active form of the APC/C, while the association of 
Cdh1 generates the interphase form (Fang et al., 1998; Schwab 
et al., 1997; Visintin et al., 1997). While Cdc20 mitotic substrates 
contain the D-box (Glotzer et al., 1991), Cdh1 could target both D-
box and non-D-box-containing proteins for degradation. As Cdc20 
itself lacks a D-box but is degraded in a Cdh1-dependent manner, 
it was ideal to use for identification of other potential degrons, and 
this resulted in the discovery of the KEN box (Pfleger and Kirschner, 
2000). Additional substrates such as proteins Nek2 and B99 were 
also found to be ubiquitylated and degraded by the natural pres-
ence of KEN boxes and, like the D-box (Glotzer et al., 1991; King 
et al., 1996), the KEN box can target heterologous proteins for 
degradation when fused to them (Pfleger and Kirschner, 2000).
The anaphase-promoting complex (or APC) was discovered 
using Xenopus extract systems (King et al., 1995) at a similar time 
to the discovery of the cyclosome in clam oocyte extracts (Sudakin 
et al., 1995). Now collectively known as the APC/C, the identifica-
tion of this multi-protein ubiquitylation complex that shows cell 
cycle stage-specific activation by Cdc20 and Cdh1 (see above), 
and the identification of cell cycle regulated degrons, combine to 
explain the cell cycle regulation of cyclin stability. It is not possible 
to overemphasize the role of Xenopus extract in facilitating the 
discovery of the APC/C and for further elucidating its function; 
for instance the identification of key binding regulatory proteins 
such as Cdc20 was made possible using exploratory experiments 
in Xenopus extract along with work in HeLa cell extracts (Fang 
et al., 1998). Similarly, the identification of Mad2L2 as a regula-
tor of Cdh1 dissociation, and the proposal of a mechanism for 
Mad2-mediated Cdc20 dissociation and Mad2L2-mediated Cdh1 
dissociation from the APC/C, were made possible through Xeno-
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pus extract-based assays of APC/C activity (Pfleger et al., 2001). 
Identification of subunits such as BIME (Peters et al., 1996) and 
additional components such as Fizzy required in APC/C activation 
(Lorca et al., 1998) were also all absolutely dependent on using 
Xenopus extract systems. It was also possible to characterize the 
kinetics of cyclin ubiquitylation to reveal more general properties 
of cyclin B protein proteasomal degradation, as described above 
(Glotzer et al., 1991). For instance, using Xenopus extract, Yu et 
al., purified the E2 enzyme UBCx from interphase egg extracts 
(Yu et al., 1996), and were thus able to identify and characterize 
a previously observed Ub-conjugating activity targeting cyclin B 
(King et al., 1995). A crucial substrate of the APC/C, securin, the 
degradation of which is required for the separation of sister chro-
matids during mitosis across vertebrate species (Zou et al., 1999) 
was first identified and its degradation characterized in Xenopus 
extract (Holloway et al., 1993). Ubiquitylation, and in particular cell 
cycle-regulated ubiquitylation, is often further regulated by additional 
post-translational modifications such as phosphorylation (Harper, 
2002; Hunter, 2007; Pagano, 1997). For instance, ubiquitylation and 
degradation of c-Mos after fertilization of Xenopus eggs is regulated 
by its phospho-status; addition of anti-Fizzy antibodies maintains 
high cyclin B/cdc2 and this prevents c-Mos dephosphorylation 
and its subsequent degradation, while anti-Fizzy antibodies had 
no effect on c-Mos dephosphorylation and destruction 15 minutes 
after activation, when cyclin B was already degraded (Castro 
et al., 2001). Cyclin degradation is itself regulated by c-Mos, 
through the activation of MAP kinase which can prevents cyclin 
B-cdc2 kinase-triggered cyclin destruction (Abrieu et al., 1996). By 
adding c-Mos protein to CSF-arrested egg extracts, the authors 
found that the cyclin degradation machinery was poised, but not 
inactivated, as release of the extract from the CSF block by addi-
tion of Ca2+-calmodulin-dependent protein kinase II allowed the 
degradation machinery to function normally (Abrieu et al., 1996). 
Most recently, Xenopus extract has been used to demonstrate that 
Cdk1 activates the APC/C through regulation of phosphorylation 
events (Fujimitsu et al., 2016).
Taken together, it is clear that work by the Kirschner (Fang et 
al., 1998; Glotzer et al., 1991; King et al., 1995; King et al., 1996; 
Murray et al., 1989; Peters et al., 1996; Pfleger et al., 2001; Pfleger 
and Kirschner, 2000; Yu et al., 1996), Hunt (Felix et al., 1989b; Felix 
et al., 1989a; Stewart et al., 1994), and Lohka (van der Velden and 
Lohka, 1993) labs in particular, alongside important contributions 
from a number of other researchers using the Xenopus extract 
system, has been formative in instructing our current understanding 
of cyclin destruction and cell cycle regulation of protein degradation. 
Ubiquitylation and DNA Replication
Protein degradation also plays a key role in regulation of DNA 
replication, and this has also been extensively characterized using 
Xenopus extracts. For instance, Geminin, an important negative 
regulator of DNA replication (McGarry and Kirschner, 1998) which 
also has a distinct role in neural induction (Kroll et al., 1998) was 
first identified by an unbiased screen set up to identify proteins 
destroyed specifically in mitosis (McGarry and Kirschner, 1998) 
and shown to regulate stability of the replication factor Cdt1 in 
Xenopus extract (Arias and Walter, 2005). Ub-mediated regula-
tion of other DNA replication factors has also been studied by 
additional methods in Xenopus extracts. For instance, in the 
initiation of DNA replication, the requirement for Cdc34 as a Ub-
conjugating enzyme to target proteins for degradation and drive 
entry into S-phase was established using methyl-Ub-supplemented 
Xenopus extracts (Yew and Kirschner, 1997). DNA replication 
was inhibited by generally blocking Ub-mediated proteasomal 
degradation. It was also postulated that Cdc34 may regulate the 
cdk inhibitor Xic1’s degradation and indeed in extracts with sperm 
nuclei added, Xic1 was efficiently degraded. It is possible to use 
antibodies to immunodeplete factors from egg extracts and then 
assay the effect on biochemical processes, and indeed, Xic1 was 
stable in Cdc34-depleted extracts (Yew and Kirschner, 1997). This 
observation suggested a close link between Xic1 degradation and 
replication, in particular for formation of a prereplication complex 
requiring Cdk2, Cdc7 and Cdc45 before Xic1 could be degraded; 
upon completion of DNA replication Xic1 is stabilized (You et al., 
2002). Findings that the Xic1 degradation rate correlated with 
the concentration of sperm nuclei in extract (Yew and Kirschner, 
1997) were explained by the finding that chromatin and a nuclear 
environment were required for Xic1 degradation to occur (You et 
al., 2002). Moreover, depletion of the chromatin-bound licensing 
factor Mcm7 from extracts inhibited both Xic1 degradation and DNA 
replication by preventing the formation of prereplication complexes 
on chromatin (You et al., 2002). Therefore a variety of Xenopus 
extract depletion studies and degradation assays, previously used 
to demonstrate the cell cycle dependence of Ub-mediated protein 
degradation, have also been modified to highlight the relationship 
between ubiquitylation and DNA replication.
Ub-mediated degradation of Neurogenin2; complex 
regulation in eggs and embryos
Ubiquitylation usually occurs on one or more lysine residues. 
However, other residues are nevertheless capable of forming 
bonds with Ub molecules and these can also target proteins for 
destruction. Non-canonical ubiquitylation describes the modification 
of protein substrates with Ub on residues other than the canonical 
lysine residue (Freiman and Tjian, 2003) and in particular on the 
N-terminal amino group; the thiol group of cysteine residues; and 
the hydroxyl group of serine and threonine residues, all of which 
have the potential [and as shown in Tables 1, 2 and 3 of (McDowell 
and Philpott, 2016), the demonstrated activity] to react with and 
covalently link to Ub. Our own laboratory has investigated these 
non-canonical ubiquitylation events by looking in detail at the 
degradation of the proneural basic helix-loop-helix (bHLH) tran-
scription factor Neurogenin2 (Ngn2, see Fig. 2). This has proved 
to be surprisingly complex.
The original observations, in Xenopus laevis interphase egg 
extract, showed that Ngn2 where all lysines had been mutated 
to alanines could nevertheless be ubiquitylated and degraded ef-
ficiently. Ub moieties could be directly added onto the N-terminus 
of Ngn2. Moreover, an N-terminally blocked lysine-less mutant 
of Ngn2 could be further ubiquitylated by bonds that were sensi-
tive to reducing agents and showing pH-dependency, implicating 
Ub linkages to cysteines, serines and threonines ((Vosper et al., 
2009), as reviewed in (Kravtsova-Ivantsiv et al., 2015; McDowell 
and Philpott, 2013; McDowell and Philpott, 2016)). Non-canonical 
ubiquitylation was of differing importance for Ngn2 protein stabil-
ity in interphase versus mitosis; we saw that mutation of all the 
cysteines in Ngn2 had no effect on stability in interphase, but was 
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stabilizing in mitotic extracts (Vosper et al., 2009). Good evidence 
for non-canonical ubiquitylation of Ngn2 driving its destruction 
was also found in extracts from neurula-stage Xenopus embryos, 
indicating that this was not an egg-specific phenomenon. Indeed, 
similar non-canonical regulation was observed in mouse embryonal 
carcinoma cells, demonstrating that even unusual regulatory mecha-
nisms first uncovered in Xenopus extracts are nevertheless active 
in vivo in frogs and in mammalian cells (McDowell et al., 2010). It 
is important to note, however, that we have since showed that the 
closely related proteins Ngn2 and Ngn3 show somewhat different 
control of ubiquitylation and destruction, and this demonstrates 
the possible need to consider these regulatory mechanisms on a 
protein by protein basis (Roark et al., 2012).
We have also undertaken a detailed investigation of the effects of 
cell cycle-regulated phosphorylation on Ngn2 protein activity (Ali et 
al., 2011; Hindley et al., 2012; McDowell, Hindley, et al., 2014) and 
it is now clear that the relationship between Ngn2 phosphorylation 
and protein stability is complex. The half-life of Ngn2 protein can 
be readily calculated by addition of radiolabelled in vitro translated 
Fig. 2. Regulation of neurogenin2 (Ngn2). Schematic illustrating points of regulation of Ngn2 by 
ubiquitylation, phosphorylation and structurally, with and without its heterodimeric E12 binding partner.
in vivo analyses, demonstrate clearly the 
versatility of Xenopus as a model system 
to study the functional consequences of 
ubiquitylation.
In addition to ubiquitylation (or some-
times even without ubiquitylation (Prakash 
et al., 2009)), unfolding initiation sites are 
required to allow protein degradation by the 
UPS (Prakash et al., 2004) and in particular 
proteins that are natively unfolded, lacking 
regular structure (intrinsically disordered 
or ID proteins (Dunker et al., 2001)) may 
be particularly susceptible to Ub-mediated 
degradation (Gsponer et al., 2008; McDow-
ell and Philpott, 2016). We investigated 
the role of ID in the degradation of Ngn2 
using Xenopus extract systems (McDowell, 
Hardwick, et al., 2014), comparing Ngn2 
and the related bHLH transcription factor 
NeuroD1, which is similarly structured but 
has very different degradation properties 
(Vosper et al., 2007). Both are ubiquity-
lated, but only Ngn2 is ubiquitylated on 
non-canonical sites (McDowell, Hardwick, 
et al., 2014), and it is degraded consider-
ably faster than NeuroD. Using the extract 
system to compare the stability of a variety 
of chimeric proteins where we swapped N-, 
C- and bHLH domains between Ngn2 and 
NeuroD1, we found that despite the disor-
der in the N- and C-terminal domains likely 
in both proteins, the bHLH domain itself 
(which is still highly disordered (Aguado-
Llera et al., 2010) but has a much more 
highly conserved sequence between the 
two proteins (Bertrand et al., 2002)) was 
the region that appeared to most greatly 
influence chimeric protein activity and 
stability (McDowell, Hardwick, et al., 2014). 
This analysis was only possible because of 
Ngn2 protein to Xenopus extracts, removing samples at increas-
ing times, and quantitating the amount of protein left after SDS 
PAGE and autoradiography ((Vosper et al., 2007), Fig. 1). Ngn2 is 
phosphorylated on multiple serine-proline motifs (Ali et al., 2011). 
Mutation of these serines to alanines does not alter the half life 
of Ngn2 in interphase or mitotic extracts. However, Ngn2 protein 
is stabilized by addition of its heterodimeric E protein binding 
partner and this is regulated by the availability of these serines; 
the phosphomutant protein is more readily stabilized than the wild-
type protein (Ali et al., 2011; McDowell, Hindley, et al., 2014). This 
is in contrast to experiments looking at another potential casein 
kinase II phosphomutant of Ngn2, T118A, which was not as well 
protected from degradation as the wild type protein (Vosper et al., 
2007). Moreover, fusion of Ub directly to the N-terminus of Ngn2 
reduced its half-life dramatically, as well as significantly inhibiting 
its ability to drive neuronal differentiation, though the effect on 
neuronal differentiation of this fusion was less pronounced for the 
phosphomutant version of the protein (Hindley et al., 2012). These 
experiments, which use egg and embryo extracts in parallel with 
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our ability to carry out a very large number of degradation assays 
using the Xenopus extract system. The other great advantage of 
Xenopus was also to have the in vivo system working in parallel 
to assess functional activity of the chimeric proteins, allowing us 
to determine the relationship between structure, activity and stabil-
ity. This relationship has proved to be remarkably complex ((Ali et 
al., 2011; Hindley et al., 2012; McDowell, Hardwick, et al., 2014; 
McDowell, Hindley, et al., 2014), see Fig. 2).
Ubiquitylation in a developmental context
Most of the insights into ubiquitylation gained using Xenopus have 
come from biochemical analyses in extract systems as described 
above, and in general, most attention has been paid to degradation 
mechanisms found in the egg. However, many proteins are degraded 
at specific times in development, and there has been some work 
in both egg and embryo extracts that has addressed control of 
ubiquitylation and destruction of proteins only found expressed at 
later developmental stages (including Ngn2 as described above). 
Indeed, the great benefit of studying Ub-mediated protein degra-
dation in Xenopus is the ability to put the biochemical information 
into a developmental context. For instance, Xic1 is targeted for 
degradation by the F-box protein Skp2, and its degradation has 
been studied in egg extracts as well as in embryos (Boix-Perales 
et al., 2007; Lin et al., 2006). The degradation of Skp2 itself by the 
APC/C has been studied in Xenopus extract by ubiquitylation and 
degradation assays (Wei et al., 2004) and its function analyzed in 
developing embryos (Boix-Perales et al., 2007). 
One of the most interesting studies of Ub-mediated protein 
degradation in a developmental context is the study of b-catenin 
regulation in extracts from eggs and embryos, with implications for 
the study of Wnt signaling in embryogenesis (Salic et al., 2000). 
Again, the strength of this approach lies in the ability to compare 
the effects of various treatments on beta-catenin stability, as well 
as other components of the Wnt signaling pathway, with devel-
opmental defects that are observed, such as problems with axis 
formation [see Table 1 in Salic et al., (2000)]. 
Concluding remarks
Since the relatively recent discovery of Ub and acceptance of 
intracellular protein catabolism, degradation of proteins by the 26S 
proteasome via the Ub-proteasome system has become an area 
of intense study across biochemical, cell biology, developmental 
and clinical disciplines. From the earliest days of ubiquitylation 
research the “cell-in-a-test-tube” system of the frog Xenopus lae-
vis has catalyzed the discovery of components of this machinery. 
Combined with the versatility of Xenopus as a developmental 
model, this has allowed investigation of the in vivo consequences 
of ubiquitylation as well as in vitro assays more geared to bio-
chemical analysis. Overall, the availability of large quantities of 
extract from the eggs of a single frog in which ubiquitylation and 
protein degradation can occur, the speed with which experiments 
can be carried out, and the ability to compare in vitro finding with 
effects in vivo in a rapid and well-characterized developmental 
context, have made Xenopus a crucial model organism for studying 
ubiquitylation and protein degradation. Its high level of versatility 
means it will remain a highly valued system for continued studies 
of Ub-mediated degradation.
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